Notably, increased expression of doublecortin-like kinase 2 (DCLK2), a serine/threonine-protein kinase, has previously been linked to reduced overall survival in CLL patients22. The gene discussed is DCLK2; the disease is B-cell chronic lymphocytic leukemia.